These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 23471820)

  • 21. Limitin, an interferon-like cytokine, transduces inhibitory signals on B-cell growth through activation of Tyk2, but not Stat1, followed by induction and nuclear translocation of Daxx.
    Aoki K; Shimoda K; Oritani K; Matsuda T; Kamezaki K; Muromoto R; Numata A; Tamiya S; Haro T; Ishikawa F; Takase K; Yamamoto T; Yumioka T; Miyamoto T; Nagafuji K; Gondo H; Nagafuchi S; Nakayama K; Harada M
    Exp Hematol; 2003 Dec; 31(12):1317-22. PubMed ID: 14662340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modifying T cell phenotypes using TYK2 inhibitor and its implications for the treatment of systemic lupus erythematosus.
    Satoh-Kanda Y; Nakayamada S; Kubo S; Yamagata K; Nawata A; Tanaka H; Kosaka S; Kanda R; Yu S; Fujita Y; Sonomoto K; Tanaka Y
    RMD Open; 2024 Jun; 10(2):. PubMed ID: 38871479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tyk2 is a therapeutic target for psoriasis-like skin inflammation.
    Ishizaki M; Muromoto R; Akimoto T; Sekine Y; Kon S; Diwan M; Maeda H; Togi S; Shimoda K; Oritani K; Matsuda T
    Int Immunol; 2014 May; 26(5):257-67. PubMed ID: 24345760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel highly selective allosteric inhibitor of tyrosine kinase 2 (TYK2) can block inflammation- and autoimmune-related pathways.
    Chen CX; Zhang W; Qu S; Xia F; Zhu Y; Chen B
    Cell Commun Signal; 2023 Oct; 21(1):287. PubMed ID: 37845748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells.
    Kamiya S; Owaki T; Morishima N; Fukai F; Mizuguchi J; Yoshimoto T
    J Immunol; 2004 Sep; 173(6):3871-7. PubMed ID: 15356135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyk2 and signal transducer and activator of transcription 1 contribute to intestinal I/R injury.
    Costantino G; Egerbacher M; Kolbe T; Karaghiosoff M; Strobl B; Vogl C; Helmreich M; Müller M
    Shock; 2008 Feb; 29(2):238-44. PubMed ID: 17693920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic potential of tyrosine kinase 2 in autoimmunity.
    Liang Y; Zhu Y; Xia Y; Peng H; Yang XK; Liu YY; Xu WD; Pan HF; Ye DQ
    Expert Opin Ther Targets; 2014 May; 18(5):571-80. PubMed ID: 24654603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional STAT3 deficiency compromises the generation of human T follicular helper cells.
    Ma CS; Avery DT; Chan A; Batten M; Bustamante J; Boisson-Dupuis S; Arkwright PD; Kreins AY; Averbuch D; Engelhard D; Magdorf K; Kilic SS; Minegishi Y; Nonoyama S; French MA; Choo S; Smart JM; Peake J; Wong M; Gray P; Cook MC; Fulcher DA; Casanova JL; Deenick EK; Tangye SG
    Blood; 2012 Apr; 119(17):3997-4008. PubMed ID: 22403255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting TYK2 for Fighting Diseases: Recent Advance of TYK2 Inhibitors.
    Du SS; Fang YQ; Zhang W; Rao GW
    Curr Med Chem; 2024; 31(20):2900-2920. PubMed ID: 38904160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the janus kinase family increases extracellular signal-regulated kinase 1/2 phosphorylation and causes endoreduplication.
    Reiterer G; Yen A
    Cancer Res; 2006 Sep; 66(18):9083-9. PubMed ID: 16982750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myxoma virus selectively disrupts type I interferon signaling in primary human fibroblasts by blocking the activation of the Janus kinase Tyk2.
    Wang F; Barrett JW; Shao Q; Gao X; Dekaban GA; McFadden G
    Virology; 2009 Apr; 387(1):136-46. PubMed ID: 19254804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. JAK and STAT proteins are expressed and activated by IFN-gamma in rat pancreatic acinar cells.
    Gallmeier E; Schäfer C; Moubarak P; Tietz A; Plössl I; Huss R; Göke B; Wagner AC
    J Cell Physiol; 2005 Apr; 203(1):209-16. PubMed ID: 15493010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Putative Role of TNK1 in Atherosclerotic Inflammation Implicating the Tyk2/STAT1 Pathway.
    Bao MH; Lv QL; Li HG; Zhang YW; Xu BF; He BS
    Mediators Inflamm; 2020; 2020():6268514. PubMed ID: 32694928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A small-molecule compound identified through a cell-based screening inhibits JAK/STAT pathway signaling in human cancer cells.
    Kim BH; Yin CH; Guo Q; Bach EA; Lee H; Sandoval C; Jayabose S; Ulaczyk-Lesanko A; Hall DG; Baeg GH
    Mol Cancer Ther; 2008 Sep; 7(9):2672-80. PubMed ID: 18790749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes.
    Pan J; Fukuda K; Saito M; Matsuzaki J; Kodama H; Sano M; Takahashi T; Kato T; Ogawa S
    Circ Res; 1999 May; 84(10):1127-36. PubMed ID: 10347087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulations.
    McInnes IB; Byers NL; Higgs RE; Lee J; Macias WL; Na S; Ortmann RA; Rocha G; Rooney TP; Wehrman T; Zhang X; Zuckerman SH; Taylor PC
    Arthritis Res Ther; 2019 Aug; 21(1):183. PubMed ID: 31375130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TYK2 kinase activity is required for functional type I interferon responses in vivo.
    Prchal-Murphy M; Semper C; Lassnig C; Wallner B; Gausterer C; Teppner-Klymiuk I; Kobolak J; Müller S; Kolbe T; Karaghiosoff M; Dinnyés A; Rülicke T; Leitner NR; Strobl B; Müller M
    PLoS One; 2012; 7(6):e39141. PubMed ID: 22723949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IκB-ζ Expression Requires Both TYK2/STAT3 Activity and IL-17-Regulated mRNA Stabilization.
    Muromoto R; Tawa K; Ohgakiuchi Y; Sato A; Saino Y; Hirashima K; Minoguchi H; Kitai Y; Kashiwakura JI; Shimoda K; Oritani K; Matsuda T
    Immunohorizons; 2019 May; 3(5):172-185. PubMed ID: 31356171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset.
    Padi SKR; Luevano LA; An N; Pandey R; Singh N; Song JH; Aster JC; Yu XZ; Mehrotra S; Kraft AS
    Oncotarget; 2017 May; 8(18):30199-30216. PubMed ID: 28415816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.